AU2014900775A0 - Heparanase inhibitors and uses thereof - Google Patents

Heparanase inhibitors and uses thereof

Info

Publication number
AU2014900775A0
AU2014900775A0 AU2014900775A AU2014900775A AU2014900775A0 AU 2014900775 A0 AU2014900775 A0 AU 2014900775A0 AU 2014900775 A AU2014900775 A AU 2014900775A AU 2014900775 A AU2014900775 A AU 2014900775A AU 2014900775 A0 AU2014900775 A0 AU 2014900775A0
Authority
AU
Australia
Prior art keywords
heparanase inhibitors
heparanase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014900775A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beta Therapeutics Pty Ltd
Original Assignee
Beta Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Beta Therapeutics Pty Ltd filed Critical Beta Therapeutics Pty Ltd
Publication of AU2014900775A0 publication Critical patent/AU2014900775A0/en
Abandoned legal-status Critical Current

Links

AU2014900775A 2014-03-07 Heparanase inhibitors and uses thereof Abandoned AU2014900775A0 (en)

Publications (1)

Publication Number Publication Date
AU2014900775A0 true AU2014900775A0 (en) 2014-03-20

Family

ID=

Similar Documents

Publication Publication Date Title
AU2015342774B2 (en) EZH2 inhibitors and uses thereof
EP3389658A4 (en) Glycosidase inhibitors and uses thereof
EP3193608A4 (en) Carm1 inhibitors and uses thereof
EP3110820A4 (en) Tyk2 inhibitors and uses thereof
EP3102576B8 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
EP3160477A4 (en) Prmt5 inhibitors and uses thereof
EP3160466A4 (en) Prmt5 inhibitors and uses thereof
EP3177288A4 (en) Prmt5 inhibitors and uses thereof
EP3193600A4 (en) Smyd inhibitors
EP3344624B8 (en) Tyk2 inhibitors and uses thereof
EP3134091A4 (en) Irak inhibitors and uses thereof
EP3099171A4 (en) Dihydropteridinone derivatives and uses thereof
EP3116503A4 (en) Hptp-beta inhibitors
EP3154590A4 (en) Combination therapy with glutaminase inhibitors
EP3092286A4 (en) Ethylene-to-liquids systems and methods
EP3262049A4 (en) Tyk2 inhibitors and uses thereof
EP3116872A4 (en) Combination therapy with glutaminase inhibitors
EP3193611A4 (en) Mk2 inhibitors and uses thereof
EP3154972A4 (en) Azamophinan derivatives and use thereof
EP3341387A4 (en) Sialyltransferase inhibitors and uses thereof
EP3302490A4 (en) Autotaxin inhibitors and uses thereof
EP3177147A4 (en) Dihydropteridinone derivatives and uses thereof
EP3177327A4 (en) Inhibitors of myh7b and uses thereof
EP3247716A4 (en) Mir-92 inhibitors and uses thereof
EP3555051A4 (en) Heparanase inhibitors and use thereof